Gubitak heterozigotnosti gena APC u slučaju vestibularnog švanoma procijenjen dvama intragenskim biljezima by Nives Pećina-Šlaus
Acta Clin Croat,  Vol. 51,  No. 4,  2012 643
Acta Clin Croat 2012; 51:643-647 Case Report
Loss of heteRozygosity of the APC gene in A 
CAse of vestibuLAR sChwAnnomA Assessed by two 
intRAgenetiC mARkeRs
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summARy – schwannomas are benign encapsulated tumors of schwann cells, the main pe-
ripheral glia cells. The majority of schwannomas arise spontaneously and account for 8% of intra-
cranial tumors. Those involving the cerebellopontine angle are schwannomas in 90% of cases. A 
case is presented of the loss of heterozygosity of the adenomatous polyposis coli (APC) gene in a 
female patient with cranial schwannoma from Croatia. The observed change of the APC gene was 
investigated by use of two intragenetic markers. in the light of novel findings on merlin connection 
to the wnt signaling reported in the literature, the finding of gross deletion in a patient with cranial 
vestibular schwannoma is a relevant genetic event. 
key words: Schwannoma; APC gene; Loss of heterozygosity; Neurinoma
Corresponding author: Nives Pećina-Šlaus, Laboratory of ne-
urooncology, Croatian institute for brain Research, school of 
medicine, university of zagreb, Šalata 12, hR-10000 zagreb, 
Croatia
e-mail: nina@mef.hr
Received february 20, 2012, accepted may 10, 2012
Introduction
Although it is well known that the main cause of 
transformation of schwann cells into schwannomas 
is ascribed to the inactivation of the neurofibromin 
2 (nf2) gene and the consecutive loss of its protein 
merlin, the intracellular mechanism of this transfor-
mation still needs to be elucidated. Recent research 
on nf2 gene demonstrates that merlin is a tumor 
suppressor that is capable of modulating a wide range 
of signaling pathways that influence cell growth, mo-
tility and apoptosis1,2. novel reports indicate merlin 
connection to the wnt signaling pathway3-5. A study 
by Lau et al.4 demonstrated the relationship between 
merlin and wnt signaling in human glioma cells. They 
showed that merlin re-expression in human glioma 
cells decreased the quantity of frizzled-1 (fzd1) re-
ceptors (fzd1 binds wnt ligands and activates wnt 
pathway), and increased the expression of molecules 
that inhibit wnt signaling, dickkopf-1 (dkk1) and 
dickkopf-2 (dkk2). so merlin re-expression reduced 
wnt signaling. Another paper by bosco et al.3 report 
on a significant increase in transcriptionally active nu-
clear beta-catenin upon merlin deletion. beta-catenin 
is the main signaling effector molecule of this pathway 
and its activation and nuclear transfer starts up the 
wnt signaling. in this contribution, the authors show 
that when merlin is lost, the tCf/Lef/beta-catenin 
transcription activity is increased. Also, nf2-/- cells 
contained an increased active beta-catenin level, and 
finally elevations in transcriptional activity of down-
stream targets of activated beta-catenin were evident 
in the absence of merlin. A paper by zhou et al.5 dem-
onstrates that canonical wnt signaling is activated in 
primary human schwannoma cells and that activated 
beta-catenin localizes in the nucleus. 
in wnt signaling, APC has the function of beta-
catenin destruction6. namely, this tumor suppressor 
has many cellular functions: as a component of the 
wnt signal transduction pathway, as a component of 
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adherens junctions, and as a component of the cy-
toskeleton stabilization. involvement of the adenom-
atous polyposis coli (APC) gene as a general tumor 
suppressor gene in a great variety of human tumors 
has been known for a long time. The gene (chromo-
some 5q21) is organized in 15 translated exons that 
encode a large multidomain protein. we tested gross 
deletions of the APC gene by use of msp i and Rsa i 
obtained genetic markers inside exon 15 and exon 11. 
since the relationship between merlin and wnt signal-
ing has been demonstrated, our finding contributes to 
the overall genetic profile of schwannoma.
Methods
DNA extraction 
Autologous blood sample was collected from the 
patient. The schwannoma tissue was frozen in liquid 
nitrogen and transported to the laboratory, where it 
was immediately transferred at -75 °C. The peripheral 
blood sample was collected in edtA and processed 
immediately. The sample was diagnosed at the de-
partment of Pathology, sestre milosrdnice university 
hospital Center, zagreb, Croatia. The local ethics 
Committee approved our study and the patient gave 
her informed consent. 
Approximately 0.5 g of tissue was homogenized 
with 1 mL extraction buffer (10 mm tris hCl, ph 
8.0; 0.1 m edtA, ph 8.0; 0.5% sodium dodecyl sul-
fate) and incubated with proteinase k (100 µg/mL; 
sigma, usA; overnight at 37 °C). Phenol chloroform 
extraction and ethanol precipitation followed. blood 
was used to extract leukocyte dnA. five mL of blood 
was lysed with 7 mL distilled water and centrifuged 
(15 min/5000 g). The pellet was then processed as for 
dnA extraction from tissue samples.
Polymerase chain reaction (PCR)
for the amplification of APC exon 11 (length 
of the obtained fragment 133 bp) the optimal reac-
tion mixture (25 µL) was: 10 pmol of each primer 
(5’-ggACtACAggCCAttgCAgAA-3’ and 
5’-ggCtACAtCtCCAAAAgtCAA-3’), 200-400 
ng template dnA, 2.5 µL 10X buffer ii, 1 mm 
mgCl2, 2.5 mm of each dntP, 0.2 µL (1u) of taq 
polymerase (Amplitaq gold, Applied biosystems, 
usA). PCR conditions were: initial denaturation, 4 
min/95 °C; denaturation, 1 min/94 °C; annealing, 
2 min/58 °C; extension, 1.5 min/72 °C; 35 cycles. 
for the amplification of fragment of exon 15 of the 
APC gene (length of the obtained fragment 550 bp) 
we used in a volume of 25 µL: 5 pmol of each primer 
(5’-AtgAtgttgACCtttCCAggg-3’ and 
5’-CttttttggCAttgCggAgCt-3’), 150 ng 
template dnA, 2.5 µL 10X buffer ii (500 mm kCl, 
100 mm tris-hCl, ph 8.3), 1.5 mm mgCl2, 2.5 
mm of each dntP, 0.2 µL (1 u) of taq polymerase. 
PCR conditions were: initial denaturation, 5 min/95 
°C; denaturation, 30 s/95 °C; annealing, 30 s/57 °C; 
extension 45+1s/72 °C; final extension 7 min/72 °C, 
35 cycles. The PCR products were analyzed on 2% 
agarose gels.
Restriction fragment length polymorphism (RFLP) 
and loss of heterozygosity
Loss of heterozygosity (Loh) of the APC gene 
was detected on the basis of RfLP of the PCR prod-
ucts using Rsa i and msp i restriction endonucleases; 
the method has been previously described in detail7. 
All the PCR experiments were repeated twice and the 
Lohs were confirmed.
Case Report
our patient was a 62-year-old female admitted to 
the university department of neurosurgery, sestre 
milosrdnice university hospital Center, manifesting 
symptoms of raised intracranial pressure including 
severe headache and nausea, dizziness and imbalance 
caused by a brain tumor. The symptoms lasted for 79 
months. The patient was without clinical nf1, nf2 or 
schwannomatosis and had no family history of brain 
tumors. using magnetic resonance imaging (mRi), 
a tumor lesion was found in the left cerebellopontine 
angle. it was a vestibular cranial schwannoma. dur-
ing the operative procedure8, the schwannoma was 
removed using a microneurosurgical technique. The 
case was classified as who grade i and specified as 
Antoni b pattern (fig. 1). The tumor was composed 
of loosely arranged spindle cells admixed with foamy 
macrophages. in some tumor cells, nuclear atypia was 
seen but mitotic activity was not observed.
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The amplified fragment of exon 15 is 550 bp long 
and in case of heterozygous samples one allele was left 
uncut and the other with the restriction site was cut 
to two fragments of approximately 275 bp. Amplifica-
tion of Rsa i polymorphic site in exon 11 generated 
a 133- bp fragment that was cut to 85- and 48- bp 
fragments by Rsa i on the allele with the site pres-
ent, and remained uncleaved on the allele without 
the restriction site. our patient was heterozygous 
for both intragenetic markers, which means that two 
bands (550+275 bp) were visible for msp i RfLP and 
3 bands for Rsa i (133-, 85- and 48- bp) in the blood 
sample of the patient.
The loss of one polymorphic allele in schwannoma 
compared to the heterozygous autologous blood sam-
ple was considered as Loh of the APC gene. both 
markers showed Loh of the APC gene in the ana-
lyzed case of vestibular schwannoma (fig. 2). 
Discussion
The role of APC gene as a component of the so-
called classic wnt signaling is primarily as a negative 
regulator of beta-catenin, the main signaling molecule 
of the pathway6. when APC is lost, the level of beta-
catenin attains oncogenic activity and beta-catenin is 
transferred to the nucleus9, where it finds a transcrip-
tion factor partner tCf/Lef. bosco et al.3 believe 
Fig. 2. LOHs of the APC gene in vestibular schwannoma 
(indicated by arrows): (A) RFLP/Rsa I/exon 11. Lane 
1: DNA standard; lane 2: schwannoma sample; lane 3: 
corresponding blood sample; (B) RFLP/Msp I/exon 15. 
Lane 1: schwannoma sample; lane 2: corresponding blood 
sample. 
Fig. 1. Vestibular schwannoma, Antoni B. The tumor was 
composed of loosely arranged Schwann cells admixed with 
foamy macrophages. In some tumor cells, nuclear hyper-
chromatism and atypia were seen. Mitoses were not pres-
ent. (H&E, X200)
that deregulated canonical wnt signaling is associated 
with nf2 loss of function. They showed a significant 
increase in transcriptionally active beta-catenin when 
merlin protein was deleted. it has been shown pre-
viously that cells lacking nf2 loose contact inhibi-
tion10 and are free to proliferate. Associated with the 
loss of contact inhibition, merlin-lacking cells are also 
known to contain defective adherens junctions11. bos-
co et al.3 indicated the relationship of merlin to the 
wnt as a possible mechanism by which nf2 deficient 
cells are able to escape contact inhibition. They also 
showed that elevated nuclear beta-catenin activity in 
nf2 deficient cells contributed to the growth pheno-
type of the cells in confluent state. They established 
the relationship between Rac1 involvement and dem-
onstrated the Rac1 mediated canonical wnt signaling 
to be essential for the loss of contact inhibition in nf2 
deficient cells. Another study on high grade human 
gliomas by Lau et al.4 discovered an increase in wnt 
signaling as a result of nf2 loss, specifically the in-
crease of tCf transcription factor activity. to inves-
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tigate whether wnt signaling is involved in schwan-
noma, zhou et al.5 used normal schwann cells in 
comparison to schwannoma cells. They demonstrated 
that canonical wnt signaling was activated in primary 
human schwannoma cells because they found acti-
vated beta-catenin localized in the nucleus and wnt 
target genes c-myc and cyclin d1 overexpressed as a 
consequence of enhanced transcriptional activities. 
These findings all collectively describe the influence 
of merlin on wnt signaling.
since APC is part of the beta-catenin destruction 
machinery, its deficiency in schwannoma cells could 
contribute to the excess cytoplasmic beta-catenin lev-
els, which enter the nucleus and activate wnt target 
genes. Although the exact molecular explanation of 
APC and merlin functional connection has not yet 
been established and merlin loss was primarily linked 
to increased beta-catenin levels, it is possible that par-
allel events that include APC deficiency also contrib-
ute to the accumulation of beta-catenin critical for the 
increased proliferation of human schwannoma cells. 
our results demonstrate Loh of the APC gene in 
a case of vestibular schwannoma, supporting reports 
on the merlin-wnt link. The report of this deletion in 
schwannoma is a novel finding that contributes to the 
overall genetic profile of schwannoma in hope for bet-
ter understanding of its pathology. 
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sažetak
gubitAk heteRozigotnosti genA APC u sLuČAJu vestibuLARnog ŠvAnomA 
PRoCiJenJen dvAmA intRAgenskim biLJezimA
N. Pećina-Šlaus
Švanomi (neurinomi, neurilemomi) su dobroćudni tumori podrijetlom od schwannovih stanica, glavnih perifernih 
glia stanica. većina švanoma javlja se spontano, tj. sporadično u populaciji, a pojavnost im iznosi 8% ukupnog broja intra-
kranijskih tumora. tumori smješteni u pontocerebelarnom kutu su u 90% slučajeva upravo švanomi. u ovom radu prika-
zan je nalaz gubitka heterozigotnosti gena APC (adenomatous polyposis coli) u bolesnice sa švanomom iz hrvatske. velika 
delecija gena APC istražena je i dokazana uporabom dvaju intragenskih biljega. u svjetlu novih spoznaja o vezi merlina, 
produkta gena nf2, i signalnog puta wnt čiji je APC sudionik, opisani nalaz o gubitku heterozigotnosti predstavlja vrije-
dan doprinos genetičkom profilu švanoma. 
ključne riječi: Švanom; Gen APC; Gubitak heterozigotnosti; Neurinom

